DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Bukowski R, Eisen T, Szczylik C et al.
Final results of the randomized phase III trial of sorafenib in advanced renal cell carcinoma: Survival and biomarker analysis.
In: J Clin Oncol 2007;
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.